4894 Stock Overview
Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cuorips Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,320.00 |
| 52 Week High | JP¥10,050.00 |
| 52 Week Low | JP¥1,952.00 |
| Beta | 0 |
| 1 Month Change | -10.00% |
| 3 Month Change | -56.54% |
| 1 Year Change | 90.64% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 229.27% |
Recent News & Updates
Here's Why We're Not At All Concerned With Cuorips' (TSE:4894) Cash Burn Situation
Sep 18
We Think Cuorips (TSE:4894) Can Easily Afford To Drive Business Growth
May 22Shareholder Returns
| 4894 | JP Biotechs | JP Market | |
|---|---|---|---|
| 7D | -5.8% | -2.5% | 0.5% |
| 1Y | 90.6% | 15.8% | 13.6% |
Return vs Industry: 4894 exceeded the JP Biotechs industry which returned 15.8% over the past year.
Return vs Market: 4894 exceeded the JP Market which returned 13.6% over the past year.
Price Volatility
| 4894 volatility | |
|---|---|
| 4894 Average Weekly Movement | 12.4% |
| Biotechs Industry Average Movement | 6.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4894's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 4894's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Takayuki Kusanagi | cuorips.co.jp |
Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services.
Cuorips Inc. Fundamentals Summary
| 4894 fundamental statistics | |
|---|---|
| Market cap | JP¥36.54b |
| Earnings (TTM) | -JP¥632.00m |
| Revenue (TTM) | JP¥23.00m |
1,505x
P/S Ratio-54.8x
P/E RatioIs 4894 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4894 income statement (TTM) | |
|---|---|
| Revenue | JP¥23.00m |
| Cost of Revenue | JP¥13.00m |
| Gross Profit | JP¥10.00m |
| Other Expenses | JP¥642.00m |
| Earnings | -JP¥632.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | -78.88 |
| Gross Margin | 43.48% |
| Net Profit Margin | -2,747.83% |
| Debt/Equity Ratio | 0% |
How did 4894 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 19:52 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cuorips Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyoichiro Shigemura | Nomura Securities Co. Ltd. |